Recent Posts
- Targeting gut microbes may be strategy for PAH treatment: Study
- Liquidia working to bring Yutrepia to US market after FDA approval
- Low-dose metformin reformulation shows promise in PAH rats
- Phase 2b trial plans for CS1 as PAH treatment endorsed by FDA
- FDA approves Yutrepia, inhaled treprostinil, for PAH and PH-ILD